Literature DB >> 32324118

Population-Based Estimates of Chronic Conditions Affecting Risk for Complications from Coronavirus Disease, United States.

Mary L Adams, David L Katz, Joseph Grandpre.   

Abstract

We estimated that 45.4% of US adults are at increased risk for complications from coronavirus disease because of cardiovascular disease, diabetes, respiratory disease, hypertension, or cancer. Rates increased by age, from 19.8% for persons 18-29 years of age to 80.7% for persons >80 years of age, and varied by state, race/ethnicity, health insurance status, and employment.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; United States; chronic conditions; complications; coronavirus disease; infection; population-based estimates; respiratory infections; risk factors; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses

Mesh:

Year:  2020        PMID: 32324118      PMCID: PMC7392427          DOI: 10.3201/eid2608.200679

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Data for China indicate that 81% of coronavirus disease (COVID-19) patients had mild cases, 14% had severe cases, and 5% had critical cases (,). The overall case-fatality rate (CFR) in China was 3.8% (), but CFRs were higher for adults with chronic conditions of cardiovascular disease (CVD; CFR 13.2%), diabetes (9.2%), chronic respiratory disease (8.0%), hypertension (8.4%), and cancer (7.6%), compared with 1.4% for patients with none of these conditions (). Our objective for this study was to use population-based US data to estimate the fraction of adults in the community who might be at increased risk for complications from COVID-19 because they reported any of the chronic conditions with a high CFR in China.

The Study

We used publicly available 2017 Behavioral Risk Factor Surveillance System (BRFSS) data () from telephone surveys of 444,649 randomly selected adults >18 years of age in the 50 states and the District of Columbia (DC). Because the BRFSS includes only noninstitutionalized adults, residents of nursing homes and assisted living facilities are among those not surveyed. We chose to use 2017 data to include hypertension, which was not addressed in 2018. Data were adjusted for the probability of selection and weighted it to be representative of the adult population in each state by age, sex, race/ethnicity, marital status, education, home ownership, and telephone type. Weights and stratum variables needed for analysis were included. We did not age-adjust results in order to reflect the age distribution of each state rather than a standard population. The median response rate for cell phone and landline surveys combined was 47.2%, ranging from 33.9% in California to 61.1% in Utah (). Reliability and validity of the BRFSS have been found to be moderate to high for many survey measures, in particular those used here, which can be checked versus medical records (). The key variable was a composite measure including adults reporting that they were ever told they had CVD (heart attack, angina, coronary heart disease, or stroke), diabetes, asthma, chronic obstructive pulmonary disease, hypertension, or cancer other than skin. We counted the number of chronic conditions for each respondent and adults who reported >1 condition and were considered to be at heightened risk for complications from COVID-19. A secondary measure was receipt of a seasonal influenza vaccination in the past year as a rough estimate of potential demand for a COVID-19 vaccine when available. Demographic measures included age group (18–29, 30–39, 40–49, 50–59, 60–69, 70–79, and >80 years of age; we created these measures by combining 5-year age groups provided in the dataset); self-reported race/ethnicity (non-Hispanic White, Black or African American, Hispanic of any race, American Indian/Alaska native, Asian/Pacific Islander, and other); health insurance coverage (any kind of healthcare coverage, including health insurance, prepaid plans such as health maintenance organizations, or government plans such as Medicare, or Indian Health Service); employment status (employed or self-employed, out of work, homemaker, student, retired, or unable to work); and state of residence, which included DC. We used Stata version 14.1 (StataCorp LP, https://www.stata.com) for analysis to account for the complex sample design of the BRFSS. We report point estimates and 95% CIs or population estimates by using weights, stratum, and primary sampling unit variables supplied in the dataset (). Missing values were excluded from analysis. Among 444,649 survey respondents, 48.7% were male, 13.9% were >70 years of age, 63.3% were white, 18.2% were retired, and 12.1% were uninsured. We obtained similar results for the study sample when 11,508 records that had missing values were removed. Overall, 45.4% (95% CI 45.1%–45.7%) of respondents fit the description of being at heightened risk for complications from COVID-19. Among all adults, 26.7% (95% CI 26.5%–27.0%) reported 1 chronic condition, 12.0% (95% CI 11.8%–12.2%) reported 2 chronic conditions, 4.7% (95% CI 4.6%–4.8%) reported 3 chronic conditions, and 2.0% (95% CI 1.9%–2.1%) reported >4 chronic conditions. Prevalence rates of separate chronic conditions were 8.5% for CVD, 6.6% for chronic obstructive pulmonary disease, 9.1% for asthma (and still have it), 10.8% for diabetes, 32.4% for hypertension, and 6.8% for cancer. Although the percentage of adults with any of the chronic conditions increased with age (Table 1), more than half (53.4%) of the total were 18–59 years of age. Rates also varied by state, race/ethnicity, insurance status, and employment, but not by sex (Table 1).
Table 1

Demographics of adults with any of 6 chronic conditions increasing risk for coronavirus disease complications, 2017 Behavioral Risk Factor Surveillance System*

Characteristic% With >1 condition (95% CI)Sample size
Total
45.4 (45.1–45.7)
433,141
Sex
M45.4 (44.9–45.9)191,193
F
45.4 (45.0–45.9)
241,695
Age, y
18–2919.8 (19.1–20.4)46,660
30–3926.8 (26.0–27.5)49,475
40–4938.1 (37.3–39.0)53,609
50–5955.1 (54.3–55.9)79,550
60–6968.0 (67.3–68.6)96,663
70–7979.5 (78.7–80.2)67,733
>80
80.7 (79.5–81.8)
33,757
Race/ethnicity
White, non-Hispanic48.0 (47.7–48.4)329,193
Black52.1 (51.1–53.1)35,087
Hispanic35.5 (34.5–36.5)31,624
American Indian/Alaska Native55.5 (52.9–58.1)8,082
Asian/Pacific Islander27.8 (25.9–29.7)10,117
Other
46.5 (44.5–48.4)
10,854
Employment
Employed/self-employed35.4 (35.0–35.8)217,975
Out of work47.0 (45.5–48.5)18,644
Homemaker39.6 (38.2–41.0)22,790
Student18.1 (16.9–19.4)11,634
Retired75.7 (75.1–76.3)128,162
Unable to work
79.3 (78.3–80.3)
30,510
Insurance status
Insured47.1 (46.8–47.5)397,495
Uninsured
33.4 (32.4–34.4)
34,052
State
AL54.2 (52.6–55.9)6,565
AK43.6 (40.7–46.5)3,124
AZ44.6 (43.6–45.6)15,086
AR53.3 (50.7–55.8)5,126
CA41.0 (39.6–42.4)9,149
CO40.0 (38.8–41.2)9,486
CT45.0 (43.7–46.3)10,298
DE48.7 (46.5–50.9)4,015
DC38.3 (36.4–40.1)4,400
FL46.9 (45.4–48.5)21,442
GA45.6 (44.0–47.2)5,895
HI44.0 (42.5–45.5)7,645
ID42.6 (40.7–44.5)4,791
IL44.9 (43.3–46.6)5,498
IN48.7 (47.5–49.8)13,489
IA44.9 (43.6–46.2)7,553
KS45.9 (45.1–46.8)21,233
KY53.2 (51.5–55.0)8,391
LA51.6 (49.7–53.5)4,680
ME49.9 (48.3–51.5)9,513
MD44.9 (43.5–46.2)13,179
MA43.4 (41.5–45.4)6,670
MI49.4 (48.2–50.6)10,584
MN38.8 (37.9–39.7)16,714
MS51.9 (49.8–54.0)4,937
MO46.2 (44.6–47.8)7,394
MT44.0 (42.3–45.8)5,793
NE43.4 (42.2–44.6)15,039
NV46.1 (43.7–48.5)3,683
NH45.9 (44.0–47.8)5,605
NJ45.6 (44.0–47.1)11,399
NM45.3 (43.5–47.0)6,376
NY42.2 (41.0–43.4)11,951
NC47.5 (45.6–49.3)4,800
ND42.0 (40.5–43.6)6,862
OH48.3 (46.9–49.6)11,975
OK50.7 (49.0–52.3)6,369
OR44.7 (43.1–46.3))5,186
PA47.8 (46.2–49.5)6,405
RI47.8 (45.9–49.8)5,444
SC49.9 (48.6–51.3)10,953
SD43.3 (41.2–45.5)6,844
TN51.1 (49.3–53.0)5,679
TX43.7 (41.8–45.5)11,941
UT37.3 (36.2–38.5)9,994
VT45.8 (44.1–47.5)6,346
VA45.2 (43.8–46.6)9,394
WA44.0 (42.9–45.1)12,822
WV58.7 (57.0–60.4)5,332
WI43.9 (42.1–45.7)5,716
WY44.0 (42.2–45.9)4,376

*Chronic conditions: cardiovascular disease, diabetes, chronic obstructive pulmonary disease, asthma, hypertension, or cancer other than skin.

*Chronic conditions: cardiovascular disease, diabetes, chronic obstructive pulmonary disease, asthma, hypertension, or cancer other than skin. State results obtained directly from Stata (Table 2) list the number of adults in each state at increased risk for complications and the percentage that number represents among all states. Results for reporting a seasonal influenza vaccination in the past year were 40.3% (95% CI 40.0%–40.6%) for all adults, including 33.7% (95% CI 33.3%–34.2%) for adults who had none of the chronic conditions and 48.0% (95% CI 47.5%–48.5%) for persons who had any of the 6 chronic conditions.
Table 2

Number of adults with any of 6 chronic conditions increasing risk for coronavirus disease complications and percentage of total in each state, 2017 Behavioral Risk Factor Surveillance System, United States*

StateNo. adults at risk% Adults at risk†
AL1,997,8641.78
AK237,2080.21
AZ2,351,7992.10
AR1,181,1051.06
CA12,240,14210.93
CO1,701,7761.52
CT1,239,5971.11
DE357,5300.32
DC213,3570.19
FL7,696,7496.88
GA3,541,3583.16
HI486,1560.43
ID534,5330.48
IL4,404,5563.93
IN2,428,1882.17
IA1,067,1330.95
KS983,3230.88
KY1,789,4441.60
LA1,806,3301.61
ME530,8090.47
MD2,054,7581.84
MA2,302,8092.06
MI3,749,2353.35
MN1,625,7781.45
MS1,150,0361.03
MO2,137,6501.91
MT356,1130.32
NE616,9050.55
NV1,048,5910.94
NH485,3400.43
NJ3,106,8802.78
NM701,5850.63
NY6,419,3215.73
NC3,713,5823.32
ND243,0960.22
OH4,268,7483.81
OK1,461,9411.31
OR1,418,6891.27
PA4,738,4144.23
RI393,0690.35
SC1,912,1341.71
SD281,1100.25
TN2,610,8002.33
TX8,977,3878.02
UT796,7210.71
VT226,3970.20
VA2,921,1712.61
WA2,464,4522.20
WV827,1930.74
WI1,949,8721.74
WY194,5440.17
Total111,943,278100

*Chronic conditions: cardiovascular disease, diabetes, chronic obstructive pulmonary disease, asthma, hypertension, or cancer other than skin.
†Values were obtained directly from state and will not agree with calculations made from raw data.

*Chronic conditions: cardiovascular disease, diabetes, chronic obstructive pulmonary disease, asthma, hypertension, or cancer other than skin.
†Values were obtained directly from state and will not agree with calculations made from raw data.

Conclusions

We estimated that 45.4% of US adults, with a wide range across age groups and states, might be at increased risks for complications from COVID-19 because of existing chronic conditions. The 18.7% who reported >2 chronic conditions might be at even greater risk on the basis of other studies (). Although complication rates increased with increasing age, 53% of those at greater risk for complications were <60 years of age. Preliminary data suggest that some of these same chronic conditions increase risk for COVID-19 complications in the United States (). Another BRFSS study that omitted hypertension and used a different definition of risk estimated that 37.6% of US adults were at risk for complications (). The list of chronic conditions used in our analysis is similar to groups at increased risk for seasonal influenza complications (), except that the influenza group includes obese adults. Obesity is much lower in China than in the United States (), which might account for that difference. Both lists include persons with chronic diseases for which behavioral risk factors have been well identified (,). In particular, the 7 risk factors of smoking, sedentary lifestyle, obesity, diabetes, hypertension, high cholesterol, and inadequate fruit and vegetable consumption together contributed to an average of 41.4% of the burden of 5 of the 6 chronic conditions used in our study (all except cancer); obesity and smoking contributed the most to the burden (). Results showing seasonal influenza vaccination rates <50% are concerning. Although a vaccine specific for this coronavirus is currently unavailable, results for seasonal influenza vaccination suggest that it might not be widely used. Our study does not address possible differences in contracting the disease, only the risk for development of complications among persons who have COVID-19 on the basis of results for China (–). Because we surveyed only noninstitutionalized adults, we excluded 1.3 million adults in nursing homes (), which almost certainly underestimates risk. Data are self-reported, and reliability and validity can vary for different measures tested (). However, as long as a respondent was told they had a chronic condition, validity was high. Age groups used for analysis did not match those used for weighting data, but that limitation should have a minimal effect on results. Low response rates could introduce bias but, as noted, validity appears high for the measures used in this study. We estimated that 45.4% of US adults are potentially at increased risk for complications from COVID-19 because of chronic conditions that are, in turn, associated with common modifiable risk factors. Such estimates will vary depending on exact criteria used and the prevalence of the risk factors associated with the chronic conditions, along with age, state of residence, and other demographic factors.
  8 in total

1.  Overweight and obesity in China.

Authors:  Yangfeng Wu
Journal:  BMJ       Date:  2006-08-19

2.  Linear association between number of modifiable risk factors and multiple chronic conditions: Results from the Behavioral Risk Factor Surveillance System.

Authors:  Mary L Adams; Joseph Grandpre; David L Katz; Douglas Shenson
Journal:  Prev Med       Date:  2017-09-14       Impact factor: 4.018

3.  The impact of key modifiable risk factors on leading chronic conditions.

Authors:  Mary L Adams; Joseph Grandpre; David L Katz; Douglas Shenson
Journal:  Prev Med       Date:  2019-01-15       Impact factor: 4.018

Review 4.  Multiple chronic conditions and healthcare costs among adults.

Authors:  Usha Sambamoorthi; Xi Tan; Arijita Deb
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2015       Impact factor: 2.217

5.  [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China].

Authors: 
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2020-02-10

Review 6.  A systematic review of publications assessing reliability and validity of the Behavioral Risk Factor Surveillance System (BRFSS), 2004-2011.

Authors:  Carol Pierannunzi; Shaohua Sean Hu; Lina Balluz
Journal:  BMC Med Res Methodol       Date:  2013-03-24       Impact factor: 4.615

7.  Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-04-03       Impact factor: 17.586

8.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

  8 in total
  34 in total

1.  Machine Learning for Prediction of Patients on Hemodialysis with an Undetected SARS-CoV-2 Infection.

Authors:  Caitlin K Monaghan; John W Larkin; Sheetal Chaudhuri; Hao Han; Yue Jiao; Kristine M Bermudez; Eric D Weinhandl; Ines A Dahne-Steuber; Kathleen Belmonte; Luca Neri; Peter Kotanko; Jeroen P Kooman; Jeffrey L Hymes; Robert J Kossmann; Len A Usvyat; Franklin W Maddux
Journal:  Kidney360       Date:  2021-01-13

2.  Lifestyle Medicine in the Midst of a Pandemic.

Authors:  Susan M Friedman; Carol Hee Barnett; Ted D Barnett
Journal:  Am J Lifestyle Med       Date:  2020-09-17

3.  The Impact of Telemedicine on Parkinson's Care during the COVID-19 Pandemic: An Italian Online Survey.

Authors:  Fabiana Ruggiero; Linda Lombi; Maria Takeko Molisso; Giorgio Fiore; Eleonora Zirone; Roberta Ferrucci; Elena Pirola; Marco Locatelli; Sergio Barbieri; Francesca Mameli
Journal:  Healthcare (Basel)       Date:  2022-06-08

4.  Is there an association between hospital staffing levels and inpatient-COVID-19 mortality rates?

Authors:  Mona Al-Amin; Md Nazmul Islam; Kate Li; Natalie Shiels; John Buresh
Journal:  PLoS One       Date:  2022-10-19       Impact factor: 3.752

Review 5.  Racial Disparities-Associated COVID-19 Mortality among Minority Populations in the US.

Authors:  Donald J Alcendor
Journal:  J Clin Med       Date:  2020-07-30       Impact factor: 4.241

6.  The association of previous influenza vaccination and coronavirus disease-2019.

Authors:  Ilan Green; Shai Ashkenazi; Eugene Merzon; Shlomo Vinker; Avivit Golan-Cohen
Journal:  Hum Vaccin Immunother       Date:  2020-12-30       Impact factor: 3.452

7.  The association of nursing home quality ratings and spread of COVID-19.

Authors:  Christianna S Williams; Qing Zheng; Alan J White; Ariana I Bengtsson; Evan T Shulman; Kurt R Herzer; Lee A Fleisher
Journal:  J Am Geriatr Soc       Date:  2021-06-07       Impact factor: 7.538

8.  Age, "Life-Cycles," and the Allocation of Scarce Medical Resources.

Authors:  Thomas May; Mark P Aulisio
Journal:  Chest       Date:  2020-06-22       Impact factor: 9.410

9.  Coronavirus Disease 2019 (COVID-19): A Modeling Study of Factors Driving Variation in Case Fatality Rate by Country.

Authors:  Jennifer Pan; Joseph Marie St Pierre; Trevor A Pickering; Natalie L Demirjian; Brandon K K Fields; Bhushan Desai; Ali Gholamrezanezhad
Journal:  Int J Environ Res Public Health       Date:  2020-11-05       Impact factor: 3.390

10.  Obesity is Associated with Worse Outcomes in COVID-19: Analysis of Early Data from New York City.

Authors:  Kaveh Hajifathalian; Sonal Kumar; Carolyn Newberry; Shawn Shah; Brett Fortune; Tibor Krisko; Shiara Ortiz-Pujols; Xi Kathy Zhou; Andrew J Dannenberg; Rekha Kumar; Reem Z Sharaiha
Journal:  Obesity (Silver Spring)       Date:  2020-09       Impact factor: 9.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.